Biotest's COVID-19 antigen reagent "makes a breakthrough again"


Recently, Biotest has taken another big step in rapid detection technology for the SARS-Cov-2. Through the efforts of the R&D team, Biotest has developed a highly sensitive fluorescent new crown antigen detection reagent and has become a manufacturer that can provide both fluorescence and colloidal gold detection reagents for the Covid-19 antigen. In comparisons of domestic and foreign experiments, the sensitivity of the Covid-19 antigen detection reagents produced by Biotest has reached more than 95% compared with nucleic acid reagents. At the same time, the detection of new coronavirus antigens in nasopharyngeal swabs can be completed at 10-20 minutes, and the results can be automatically interpreted by a fluorescent immunoassay analyzer, which resolves individual differences in results caused by differences in visual interpretation of colloidal gold reagents. Biotest will continue to provide innovative, immediate and high-quality diagnostic products and solutions for the severe and complex global epidemic situation.


Another news: After review and confirmation by the Ministry of Commerce, Biotest's Covid-19 antigen detection reagent has officially entered the list of medical material manufacturers that have obtained foreign standard certification or registration.

Por favor, rellene su información de contacto
Para que podamos resolver sus necesidades de manera eficiente